Somatostatin receptors in congenital hyperinsulinism: Biology to bedside

Somatostatin receptors in congenital hyperinsulinism: Biology to bedside

Congenital hyperinsulinism (CHI), although a rare disease, is an important cause of severe hypoglycemia in early infancy and childhood, causing preventable morbidity and mortality. Prompt diagnosis and appropriate treatment is necessary to prevent hypoglycaemia mediated brain damage. At present, the...

Full description

Bibliographic Details
Main Authors: Mirjam E. van Albada, Klaus Mohnike, Mark J. Dunne, Indi Banerjee, Stephen F. Betz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
congenital hyperinsulinemia
somatostatin
receptor expression
hypoglycemia
insulin
glucagon
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.921357/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.921357/full

Similar Items